Literature DB >> 6322712

Cushing's disease with 'normal suppression' due to decreased dexamethasone clearance.

L P Kapcala, S M Hamilton, A W Meikle.   

Abstract

Suppression of urinary corticosteroids during low-dose dexamethasone testing (0.5 mg every six hours eight times) has commonly been recognized as a response that excludes the diagnosis of Cushing's syndrome. Although "normal suppression" has been reported previously in Cushing's disease, rarely has an explanation been provided for this aberrant response. We report a case of proven Cushing's disease in which normal suppression was observed with low-dose dexamethasone testing. Further study suggested that this phenomenon, which is not widely recognized, was related to an abnormally decreased clearance of dexamethasone. We therefore suggest that whenever responses to testing appear discordant with the clinical index of suspicion, simultaneous plasma dexamethasone and cortisol levels should be obtained to exclude abnormalities in dexamethasone clearance.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6322712

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  4 in total

1.  The dexamethasone-suppressed corticotropin-releasing hormone stimulation test differentiates mild Cushing's disease from normal physiology.

Authors:  J A Yanovski; G B Cutler; G P Chrousos; L K Nieman
Journal:  J Clin Endocrinol Metab       Date:  1998-02       Impact factor: 5.958

Review 2.  [Factors interfering with the dexamethasone suppression test].

Authors:  R Liebl
Journal:  Klin Wochenschr       Date:  1986-06-16

Review 3.  Transsphenoidal surgery for Cushing's syndrome.

Authors:  J Nabarro
Journal:  J R Soc Med       Date:  1986-05       Impact factor: 5.344

4.  Association between posttest dexamethasone and cortisol concentrations in the 1 mg overnight dexamethasone suppression test.

Authors:  Bjørn O Asvold; Valdemar Grill; Ketil Thorstensen; Marit R Bjørgaas
Journal:  Endocr Connect       Date:  2012-08-30       Impact factor: 3.335

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.